E.E.S

Product NDC: 24338-134
11-digit product format: 243380134
Labeler code: 24338
Product ID: 24338-134_0ca69356-c906-e9a9-e063-6394a90a9395
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Erythromycin Ethylsuccinate
Dosage form: GRANULE, FOR SUSPENSION
Route: ORAL
Labeler: Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)
Application: NDA050207
Marketing category: NDA
Marketing start: 2011-04-18
Substance: ERYTHROMYCIN ETHYLSUCCINATE
Active strength: 200 mg/5mL
Pharmacologic classes: Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N050207-001	E.E.S.	ERYTHROMYCIN ETHYLSUCCINATE	EQ 200MG BASE/5ML	GRANULE / ORAL	AB	RLD, Approved before 1982
N050207-002	ERYPED	ERYTHROMYCIN ETHYLSUCCINATE	EQ 400MG BASE/5ML	GRANULE / ORAL	AB	RLD, RS, Approved before 1982
N050207-003	ERYPED	ERYTHROMYCIN ETHYLSUCCINATE	EQ 200MG BASE/5ML	GRANULE / ORAL	AB	RLD	1987-03-30

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-product	TE code
N050207-001	AB
N050207-002	AB
N050207-003	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 123 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N050207-001	E.E.S.	EQ 200MG BASE/5ML	GRANULE / ORAL	AB	RLD, Approved before 1982		`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N050207-002	ERYPED	EQ 400MG BASE/5ML	GRANULE / ORAL	AB	RLD, RS, Approved before 1982		`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N050207-003	ERYPED	EQ 200MG BASE/5ML	GRANULE / ORAL	AB	RLD	1987-03-30	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N050207-001	E.E.S.	EQ 200MG BASE/5ML	GRANULE / ORAL	AB	RLD, Approved before 1982		`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N050207-002	ERYPED	EQ 400MG BASE/5ML	GRANULE / ORAL	AB	RLD, RS, Approved before 1982		`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N050207-003	ERYPED	EQ 200MG BASE/5ML	GRANULE / ORAL	AB	RLD	1987-03-30	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N050207-001	E.E.S.	EQ 200MG BASE/5ML	GRANULE / ORAL	AB	RLD, Approved before 1982		`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N050207-002	ERYPED	EQ 400MG BASE/5ML	GRANULE / ORAL	AB	RLD, RS, Approved before 1982		`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N050207-003	ERYPED	EQ 200MG BASE/5ML	GRANULE / ORAL	AB	RLD	1987-03-30	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N050207-001	E.E.S.	EQ 200MG BASE/5ML	GRANULE / ORAL	AB	RLD, Approved before 1982		`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N050207-002	ERYPED	EQ 400MG BASE/5ML	GRANULE / ORAL	AB	RLD, RS, Approved before 1982		`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N050207-003	ERYPED	EQ 200MG BASE/5ML	GRANULE / ORAL	AB	RLD	1987-03-30	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N050207-001	E.E.S.	EQ 200MG BASE/5ML	GRANULE / ORAL	AB	RLD, Approved before 1982		`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N050207-002	ERYPED	EQ 400MG BASE/5ML	GRANULE / ORAL	AB	RLD, RS, Approved before 1982		`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N050207-003	ERYPED	EQ 200MG BASE/5ML	GRANULE / ORAL	AB	RLD	1987-03-30	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N050207-001	E.E.S.	EQ 200MG BASE/5ML	GRANULE / ORAL	AB	RLD, Approved before 1982		`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N050207-002	ERYPED	EQ 400MG BASE/5ML	GRANULE / ORAL	AB	RLD, RS, Approved before 1982		`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N050207-003	ERYPED	EQ 200MG BASE/5ML	GRANULE / ORAL	AB	RLD	1987-03-30	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N050207-001	E.E.S.	EQ 200MG BASE/5ML	GRANULE / ORAL	AB	RLD, Approved before 1982		`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N050207-002	ERYPED	EQ 400MG BASE/5ML	GRANULE / ORAL	AB	RLD, RS, Approved before 1982		`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N050207-003	ERYPED	EQ 200MG BASE/5ML	GRANULE / ORAL	AB	RLD	1987-03-30	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N050207-001	E.E.S.	EQ 200MG BASE/5ML	GRANULE / ORAL	AB	RLD, Approved before 1982		`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N050207-002	ERYPED	EQ 400MG BASE/5ML	GRANULE / ORAL	AB	RLD, RS, Approved before 1982		`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N050207-003	ERYPED	EQ 200MG BASE/5ML	GRANULE / ORAL	AB	RLD	1987-03-30	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N050207-001	E.E.S.	EQ 200MG BASE/5ML	GRANULE / ORAL	AB	RLD, Approved before 1982		`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N050207-002	ERYPED	EQ 400MG BASE/5ML	GRANULE / ORAL	AB	RLD, RS, Approved before 1982		`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N050207-003	ERYPED	EQ 200MG BASE/5ML	GRANULE / ORAL	AB	RLD	1987-03-30	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N050207-001	E.E.S.	EQ 200MG BASE/5ML	GRANULE / ORAL	AB	RLD, Approved before 1982		`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N050207-002	ERYPED	EQ 400MG BASE/5ML	GRANULE / ORAL	AB	RLD, RS, Approved before 1982		`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N050207-003	ERYPED	EQ 200MG BASE/5ML	GRANULE / ORAL	AB	RLD	1987-03-30	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N050207-001	E.E.S.	EQ 200MG BASE/5ML	GRANULE / ORAL	AB	RLD, Approved before 1982		`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N050207-002	ERYPED	EQ 400MG BASE/5ML	GRANULE / ORAL	AB	RLD, RS, Approved before 1982		`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N050207-003	ERYPED	EQ 200MG BASE/5ML	GRANULE / ORAL	AB	RLD	1987-03-30	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N050207-001	E.E.S.	EQ 200MG BASE/5ML	GRANULE / ORAL	AB	RLD, Approved before 1982		`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N050207-002	ERYPED	EQ 400MG BASE/5ML	GRANULE / ORAL	AB	RLD, RS, Approved before 1982		`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N050207-003	ERYPED	EQ 200MG BASE/5ML	GRANULE / ORAL	AB	RLD	1987-03-30	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N050207-001	E.E.S.	EQ 200MG BASE/5ML	GRANULE / ORAL	AB	RLD, Approved before 1982		`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N050207-002	ERYPED	EQ 400MG BASE/5ML	GRANULE / ORAL	AB	RLD, RS, Approved before 1982		`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N050207-003	ERYPED	EQ 200MG BASE/5ML	GRANULE / ORAL	AB	RLD	1987-03-30	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N050207-001	E.E.S.	EQ 200MG BASE/5ML	GRANULE / ORAL	AB	RLD, Approved before 1982		`8072bd15b7f6…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 4 · 123 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N050207-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N050207-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N050207-003	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N050207-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N050207-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N050207-003	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N050207-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N050207-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N050207-003	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N050207-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N050207-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N050207-003	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N050207-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N050207-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N050207-003	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N050207-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N050207-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N050207-003	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N050207-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N050207-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N050207-003	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N050207-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N050207-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N050207-003	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N050207-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N050207-002	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N050207-003	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N050207-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N050207-002	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N050207-003	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N050207-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N050207-002	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N050207-003	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N050207-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N050207-002	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N050207-003	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N050207-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N050207-002	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N050207-003	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N050207-001	AB	1	`8072bd15b7f6…`

Additional Listing Data#

Finished product: Yes
Brand name base: E.E.S
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
ERYTHROMYCIN ETHYLSUCCINATE	200 mg/5mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
1014KSJ86F	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 4 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
686400	Internal RxNorm lookup
686405	Internal RxNorm lookup
863603	Internal RxNorm lookup
863606	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
b455bbdb-a3f1-470f-aa5f-ed83ac2e228d	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
d329c2e1-5ae8-4e64-aea0-77ecea3fa1ab	Product name	3	20250717
3b331500-3b74-bd2b-fede-d46839f2f4d5	Product name	6	20240313
fdae2630-eae0-4769-abfd-8f33d5b771b4	Product name	3	20240202
8c898317-b543-1e4e-254f-84cec2f3f57e	Product name	2	20191002
64ae94c0-3212-d73a-92da-9e6dd85c6ebe	Product name	2	20180118
edcfa1cf-915f-1a4c-d0aa-508cc66e70d9	Product name	2	20170816
ad75fcfd-a339-42a1-9c60-43ba2c654cfa	Product name	1	20170810
57850177-5927-151f-e1fa-7e2ca47f81e5	Product name	1	20140508
8ee71591-1d8f-e24e-242b-bfef131e3168	Product name	1	20140508
bff5cf99-0f45-fa15-2a76-b160c3c4cc3c	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
24338-134-02	E.E.S	100 mL in 1 BOTTLE	GRANULE, FOR SUSPENSION	100		21

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
24338-134-02	ML - Milliliter	24338-134	621456e6-9b45-4f06-bcf2-f735a5dd1998	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
Erythromycin Ethylsuccinate	ACTIVE INGREDIENT	1014KSJ86F	E.E.S 400 (ERYTHROMYCIN ETHYLSUCCINATE) TABLET E.E.S (ERYTHROMYCIN ETHYLSUCCINATE) GRANULE, FOR SUSPENSION [ARBOR PHARMACEUTICALS, INC.]	11
Erythromycin	ACTIVE MOIETY	63937KV33D	E.E.S 400 (ERYTHROMYCIN ETHYLSUCCINATE) TABLET E.E.S (ERYTHROMYCIN ETHYLSUCCINATE) GRANULE, FOR SUSPENSION [ARBOR PHARMACEUTICALS, INC.]	11
carboxymethylcellulose sodium	INACTIVE INGREDIENT	K679OBS311	E.E.S 400 (ERYTHROMYCIN ETHYLSUCCINATE) TABLET E.E.S (ERYTHROMYCIN ETHYLSUCCINATE) GRANULE, FOR SUSPENSION [ARBOR PHARMACEUTICALS, INC.]	11
Citric Acid Monohydrate	INACTIVE INGREDIENT	2968PHW8QP	E.E.S 400 (ERYTHROMYCIN ETHYLSUCCINATE) TABLET E.E.S (ERYTHROMYCIN ETHYLSUCCINATE) GRANULE, FOR SUSPENSION [ARBOR PHARMACEUTICALS, INC.]	11
D&C Red No. 30	INACTIVE INGREDIENT	2S42T2808B	E.E.S 400 (ERYTHROMYCIN ETHYLSUCCINATE) TABLET E.E.S (ERYTHROMYCIN ETHYLSUCCINATE) GRANULE, FOR SUSPENSION [ARBOR PHARMACEUTICALS, INC.]	11
D&C Yellow No. 10	INACTIVE INGREDIENT	35SW5USQ3G	E.E.S 400 (ERYTHROMYCIN ETHYLSUCCINATE) TABLET E.E.S (ERYTHROMYCIN ETHYLSUCCINATE) GRANULE, FOR SUSPENSION [ARBOR PHARMACEUTICALS, INC.]	11
FD&C Red No. 3	INACTIVE INGREDIENT	PN2ZH5LOQY	E.E.S 400 (ERYTHROMYCIN ETHYLSUCCINATE) TABLET E.E.S (ERYTHROMYCIN ETHYLSUCCINATE) GRANULE, FOR SUSPENSION [ARBOR PHARMACEUTICALS, INC.]	11
FD&C Red No. 40	INACTIVE INGREDIENT	WZB9127XOA	E.E.S 400 (ERYTHROMYCIN ETHYLSUCCINATE) TABLET E.E.S (ERYTHROMYCIN ETHYLSUCCINATE) GRANULE, FOR SUSPENSION [ARBOR PHARMACEUTICALS, INC.]	11
magnesium aluminum silicate	INACTIVE INGREDIENT	6M3P64V0NC	E.E.S 400 (ERYTHROMYCIN ETHYLSUCCINATE) TABLET E.E.S (ERYTHROMYCIN ETHYLSUCCINATE) GRANULE, FOR SUSPENSION [ARBOR PHARMACEUTICALS, INC.]	11
magnesium stearate	INACTIVE INGREDIENT	70097M6I30	E.E.S 400 (ERYTHROMYCIN ETHYLSUCCINATE) TABLET E.E.S (ERYTHROMYCIN ETHYLSUCCINATE) GRANULE, FOR SUSPENSION [ARBOR PHARMACEUTICALS, INC.]	11
polacrilin potassium	INACTIVE INGREDIENT	0BZ5A00FQU	E.E.S 400 (ERYTHROMYCIN ETHYLSUCCINATE) TABLET E.E.S (ERYTHROMYCIN ETHYLSUCCINATE) GRANULE, FOR SUSPENSION [ARBOR PHARMACEUTICALS, INC.]	11
polyethylene glycols	INACTIVE INGREDIENT	3WJQ0SDW1A	E.E.S 400 (ERYTHROMYCIN ETHYLSUCCINATE) TABLET E.E.S (ERYTHROMYCIN ETHYLSUCCINATE) GRANULE, FOR SUSPENSION [ARBOR PHARMACEUTICALS, INC.]	11
powdered cellulose	INACTIVE INGREDIENT	SMD1X3XO9M	E.E.S 400 (ERYTHROMYCIN ETHYLSUCCINATE) TABLET E.E.S (ERYTHROMYCIN ETHYLSUCCINATE) GRANULE, FOR SUSPENSION [ARBOR PHARMACEUTICALS, INC.]	11
propylene glycol	INACTIVE INGREDIENT	6DC9Q167V3	E.E.S 400 (ERYTHROMYCIN ETHYLSUCCINATE) TABLET E.E.S (ERYTHROMYCIN ETHYLSUCCINATE) GRANULE, FOR SUSPENSION [ARBOR PHARMACEUTICALS, INC.]	11
sodium citrate	INACTIVE INGREDIENT	1Q73Q2JULR	E.E.S 400 (ERYTHROMYCIN ETHYLSUCCINATE) TABLET E.E.S (ERYTHROMYCIN ETHYLSUCCINATE) GRANULE, FOR SUSPENSION [ARBOR PHARMACEUTICALS, INC.]	11
sorbic acid	INACTIVE INGREDIENT	X045WJ989B	E.E.S 400 (ERYTHROMYCIN ETHYLSUCCINATE) TABLET E.E.S (ERYTHROMYCIN ETHYLSUCCINATE) GRANULE, FOR SUSPENSION [ARBOR PHARMACEUTICALS, INC.]	11
starch, corn	INACTIVE INGREDIENT	O8232NY3SJ	E.E.S 400 (ERYTHROMYCIN ETHYLSUCCINATE) TABLET E.E.S (ERYTHROMYCIN ETHYLSUCCINATE) GRANULE, FOR SUSPENSION [ARBOR PHARMACEUTICALS, INC.]	11
sucrose	INACTIVE INGREDIENT	C151H8M554	E.E.S 400 (ERYTHROMYCIN ETHYLSUCCINATE) TABLET E.E.S (ERYTHROMYCIN ETHYLSUCCINATE) GRANULE, FOR SUSPENSION [ARBOR PHARMACEUTICALS, INC.]	11
titanium dioxide	INACTIVE INGREDIENT	15FIX9V2JP	E.E.S 400 (ERYTHROMYCIN ETHYLSUCCINATE) TABLET E.E.S (ERYTHROMYCIN ETHYLSUCCINATE) GRANULE, FOR SUSPENSION [ARBOR PHARMACEUTICALS, INC.]	11

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
24338-134	E.E.S 400 (ERYTHROMYCIN ETHYLSUCCINATE) TABLET E.E.S (ERYTHROMYCIN ETHYLSUCCINATE) GRANULE, FOR SUSPENSION [AZURITY PHARMACEUTICALS, INC. (FORMERLY ARBOR PHARMACEUTICALS)]	21	Current NDC, Legacy NDC, 1 package rows	20231217_b455bbdb-a3f1-470f-aa5f-ed83ac2e228d.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 4 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
E.E.S 400	ERYTHROMYCIN ETHYLSUCCINATE	Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)	b455bbdb-a3f1-470f-aa5f-ed83ac2e228d	2023-12-16	Warnings, Adverse reactions	Exact identifier application applno (NDA): 050207 application number: NDA050207 ndc (product): 24338-134
Ery-Ped	ERYTHROMYCIN ETHYLSUCCINATE	Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)	04775721-ab87-4b66-808c-d67a21032385	2023-12-16	Warnings, Adverse reactions	Exact identifier application applno (NDA): 050207 application number: NDA050207
ERYTHROMYCIN ETHYLSUCCINATE	ERYTHROMYCIN ETHYLSUCCINATE	Wilshire Pharmaceuticals	86d6353c-2b58-4219-b31d-fb5b97789094	2020-09-24	Warnings, Adverse reactions	Exact identifier application applno (NDA): 050207 application number: NDA050207
Erythromycin Ethylsuccinate	ERYTHROMYCIN ETHYLSUCCINATE	Wilshire Pharmaceuticals Inc.	f4a3fffd-ce02-450f-bbcc-d425374e3e32	2019-01-29	Warnings, Adverse reactions	Exact identifier application applno (NDA): 050207 application number: NDA050207

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
1014KSJ86F	ERYTHROMYCIN ETHYLSUCCINATE	1264-62-6	ERYTHROMYCIN ETHYLSUCCINATE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
863603	E.E.S. 200 MG in 5 mL Oral Suspension	PSN	b455bbdb-a3f1-470f-aa5f-ed83ac2e228d	21
863606	E.E.S. 400 MG Oral Tablet	PSN	b455bbdb-a3f1-470f-aa5f-ed83ac2e228d	21
686400	erythromycin ethylsuccinate 200 MG in 5 mL Oral Suspension	PSN	b455bbdb-a3f1-470f-aa5f-ed83ac2e228d	21
686405	erythromycin ethylsuccinate 400 MG Oral Tablet	PSN	b455bbdb-a3f1-470f-aa5f-ed83ac2e228d	21
863603	erythromycin ethylsuccinate 40 MG/ML Oral Suspension [E.E.S.]	SBD	b455bbdb-a3f1-470f-aa5f-ed83ac2e228d	21
863606	erythromycin ethylsuccinate 400 MG Oral Tablet [E.E.S.]	SBD	b455bbdb-a3f1-470f-aa5f-ed83ac2e228d	21
686400	erythromycin ethylsuccinate 40 MG/ML Oral Suspension	SCD	b455bbdb-a3f1-470f-aa5f-ed83ac2e228d	21
686405	erythromycin ethylsuccinate 400 MG Oral Tablet	SCD	b455bbdb-a3f1-470f-aa5f-ed83ac2e228d	21
863603	E.E.S. 200 MG per 5 ML Oral Suspension	SY	b455bbdb-a3f1-470f-aa5f-ed83ac2e228d	21
863603	E.E.S. 200 Oral Suspension	SY	b455bbdb-a3f1-470f-aa5f-ed83ac2e228d	21
863603	E.E.S. 40 MG/ML Oral Suspension	SY	b455bbdb-a3f1-470f-aa5f-ed83ac2e228d	21
863606	E.E.S. 400 MG Oral Tablet	SY	b455bbdb-a3f1-470f-aa5f-ed83ac2e228d	21
686400	EES 40 MG/ML Oral Suspension	SY	b455bbdb-a3f1-470f-aa5f-ed83ac2e228d	21
863603	EES 40 MG/ML Oral Suspension [E.E.S.]	SY	b455bbdb-a3f1-470f-aa5f-ed83ac2e228d	21
686405	EES 400 MG Oral Tablet	SY	b455bbdb-a3f1-470f-aa5f-ed83ac2e228d	21
863606	EES 400 MG Oral Tablet [E.E.S.]	SY	b455bbdb-a3f1-470f-aa5f-ed83ac2e228d	21
686400	erythromycin ethylsuccinate 200 MG per 5 ML Oral Suspension	SY	b455bbdb-a3f1-470f-aa5f-ed83ac2e228d	21

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
24338-134-02	24338013402	100 mL in 1 BOTTLE (24338-134-02)	100 ml	2011-04-18	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
E.E.S. ® (ERYTHROMYCIN ETHYLSUCCINATE)	Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)	2023-12-16	HUMAN PRESCRIPTION DRUG LABEL	21